The diagnosis of Parkinson's disease is largely clinical and depends on the presence of a specific set of symptoms and signs (the initial core features being ...

Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines.

This guideline is over 10 years old and should not be used. If you feel that this topic should be updated, please propose a topic on our website.

12 янв. 2010 г. · This article summarises the recommendations from the Scottish Intercollegiate Guideline Network (SIGN) on the diagnosis and drug management of Parkinson's ...

13 июн. 2019 г. · The current guideline SIGN 113 reflects an out of date SMC review. Section 5.5.6 would be amended to reflect the positive recommendation by SMC ...

19 июл. 2017 г. · This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of ...

Cephalalgia 1993;13:136-7. GUIDELINES. Diagnosis and pharmacological management of. Parkinson's disease: summary of SIGN guidelines. D G Grosset, ...

6 июн. 2024 г. · The aim of this German national guideline is to optimize the clinical care of patients with Parkinson's disease (PD) in terms of diagnostics, drug and surgical ...

4 июн. 2020 г. · American Academy of Neurology (AAN). In 2010, the AAN released guidelines on the treatment of nonmotor symptoms of Parkinson disease.

The updated Guideline provides a comprehensive review of this complex disease with an emphasis on communication, diagnosis and progression, treatment and non- ...